Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M306568200 on November 21, 2003

J. Biol. Chem., Vol. 279, Issue 7, 5088-5099, February 13, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/7/5088    most recent
M306568200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cartoni, A.
Right arrow Articles by Minotti, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cartoni, A.
Right arrow Articles by Minotti, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Oxidative Degradation of Cardiotoxic Anticancer Anthracyclines to Phthalic Acids

NOVEL FUNCTION FOR FERRYLMYOGLOBIN*

Antonella Cartoni{ddagger}§, Pierantonio Menna§, Emanuela Salvatorelli§, Daniela Braghiroli||, Rossella Giampietro¶, Fabio Animati{ddagger}, Andrea Urbani¶, Piero Del Boccio¶, and Giorgio Minotti¶**

From the {ddagger}Department of Chemistry, Menarini Ricerche, 00040 Pomezia, Rome, ||G. d'Annunzio University School of Pharmacy, G. d'Annunzio University School of Medicine, and "Centro Studi sull' Invecchiamento" (Ce.S.I), 66013 Chieti, Italy

We show that the pseudoperoxidase activity of ferrylmyoglobin (MbIV) promotes oxidative degradation of doxorubicin (DOX), an anticancer anthracycline known to induce severe cardiotoxicity. MbIV, formed in vitro by reacting horse heart MbIII with H2O2, caused disappearance of the spectrum of DOX at 477 nm and appearance of UV-absorbing chromophores that indicated opening and degradation of its tetracyclic ring. Electron spray ionization mass spectrometry analyses of DOX/MbIV ultrafiltrates showed that DOX degradation resulted in formation of 3-methoxyphthalic acid, the product of oxidative modifications of its methoxy-substituted ring D. Other methoxy-substituted anthracyclines similarly released 3-methoxyphthalic acid after oxidation by MbIV, whereas demethoxy analogs released simple phthalic acid. Kinetic and stoichiometric analyses of reactions between DOX and MbIII/H2O2 or hemin/H2O2 showed that the porphyrin radical of MbIV-compound I and the iron-oxo moiety of MbIV-compound II were sequentially involved in oxidizing DOX; however, oxidation by compound I formed more 3-methoxyphthalic acid than oxidation by compound II. Sizeable amounts of 3-methoxyphthalic acid were formed in the heart of mice treated with DOX, in human myocardial biopsies exposed to DOX in vitro, and in human cardiac cytosol that oxidized DOX after activation of its endogenous myoglobin by H2O2. Importantly, H9c2 cardiomyocytes were damaged by low concentrations of DOX but could tolerate concentrations of 3-methoxyphthalic acid higher than those measured in murine or human myocardium. These results unravel a novel function for MbIV in the oxidative degradation of anthracyclines to phthalic acids and suggest that this may serve a salvage pathway against cardiotoxicity.


Received for publication, June 20, 2003 , and in revised form, October 17, 2003.

* This work was supported by Associazione Italiana Ricerca sul Cancro, MURST COFIN 2001 and 2002, FIRB RBNE 014HJ3-002, and "Center of Excellence on Aging at the University of Chieti" (to G. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors contributed equally to this work.

** To whom correspondence should be addressed: G. d'Annunzio University School of Medicine, Centro Studi sull'Invecchiamento, Rm. 412, Via dei Vestini, 66013 Chieti, Italy. Tel.: 39-0871-541391; Fax: 39-0871-541480; E-mail: gminotti{at}unich.it.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
P. Menna, E. Salvatorelli, and G. Minotti
Doxorubicin Degradation in Cardiomyocytes
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 408 - 419.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. J. Reszka, L. H. Britigan, and B. E. Britigan
Oxidation of Anthracyclines by Peroxidase Metabolites of Salicylic Acid
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 283 - 290.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. J. Reszka, B. A. Wagner, L. M. Teesch, B. E. Britigan, D. R. Spitz, and C. P. Burns
Inactivation of Anthracyclines by Cellular Peroxidase
Cancer Res., July 15, 2005; 65(14): 6346 - 6353.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
Pharmacol. Rev., June 1, 2004; 56(2): 185 - 229.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement